Yes. At the time of publishing there is one COVID-19 vaccine, COMIRNATY, approved for use in Australia.1
COMIRNATY is an mRNA vaccine approved to prevent COVID-19, the disease caused by SARS-COV2, in people aged 16 years and older.
Read more about mRNA vaccines by scrolling down to the section ’How do mRNA vaccines work?’
You can download the Approved Product Information or the Consumer Medicine Information (CMI) for COMIRNATY from the TGA website.
In some countries, including the United Kingdom, United States and Canada, rollout of several COVID-19 vaccines to select groups eg, frontline workers and the elderly, has commenced under interim and/or emergency use agreements.
The number of COVID-19 vaccines in development and being trialled is constantly changing. A snapshot of the vaccine landscape is available on the NCIRS
website, with a more in depth summary of trials available through the WHO.
Monitoring of potential vaccines continues
The European Medicines Agency (EMA), and members of the Access Consortium – including Australia, Canada, Singapore, Switzerland and the UK – will continue to evaluate the evidence of each potential vaccine as they prepare for regulatory review.2
The TGA continues to actively monitor COVID-19 vaccine development occurring both in Australia and around the world. In addition to the provisionally approved Pfizer vaccine, the TGA has granted ‘provisional determinations’ in relation to three COVID-19 vaccines in Australia. Find out more about the COVID-19 vaccines undergoing evaluation
Read more about how vaccines are approved on the TGA website COVID-19 vaccine: Information for consumers and health professionals
Read more about provisional determinations on the TGA website.